In this session, I’ll explore how Quarto can be used to create dynamic, interactive reports for pharma research and development. I’ll show how to integrate Observable JS for real-time data exploration and visualization, while incorporating plots from both R and Python into a single, cohesive report. Using Quarto’s multi-language support, I’ll demonstrate how to combine R’s power with Python’s capabilities seamlessly. A key highlight will be the CloseRead extension, a custom Quarto format that enables scrollytelling features in HTML documents. With CloseRead, I’ll showcase how to build interactive narratives that make your reports more engaging and easier to understand. Whether you're presenting clinical trial data or drug discovery insights, Quarto offers an innovative way to tell your data story. Whether it’s regulatory reports, progress summaries, or even model results, Quarto’s flexibility can save time and reduce errors. Join me to see how we can make pharma reporting more efficient, transparent, and open.
Jaspreet Pabla
Interactive and Reproducible Reports with Quarto
In this session, I’ll explore how Quarto can be used to create dynamic, interactive reports for pharma research and development. I’ll show how to integrate Observable JS for real-time data exploration and visualization, while incorporating plots from both R and Python into a single, cohesive report. Using Quarto’s multi-language support, I’ll demonstrate how to combine R’s power with Python’s capabilities seamlessly. A key highlight will be the CloseRead extension, a custom Quarto format that enables scrollytelling features in HTML documents. With CloseRead, I’ll showcase how to build interactive narratives that make your reports more engaging and easier to understand. Whether you're presenting clinical trial data or drug discovery insights, Quarto offers an innovative way to tell your data story. Whether it’s regulatory reports, progress summaries, or even model results, Quarto’s flexibility can save time and reduce errors. Join me to see how we can make pharma reporting more efficient, transparent, and open.